X0306 4 2020-07-09 0 0001137883 BRAINSTORM CELL THERAPEUTICS INC. BCLI 0001521843 ACC International Holdings Ltd. MORGAN & MORGAN BUILDING PASEA ESTATE, ROAD TOWN TORTOLA D8 VG 1110 VIRGIN ISLANDS, BRITISH 0 0 0 1 Member of 10% owner group Common Stock 2020-07-09 4 S 0 3500 13.1253 D 135306 D Common Stock 2020-07-10 4 S 0 2000 13.35 D 133306 D Common Stock 2020-07-13 4 S 0 40000 13.5238 D 93306 D Common Stock 2020-07-15 4 S 0 18430 13.1153 D 74876 D Common Stock 2020-07-16 4 S 0 7823 13.4668 D 67053 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.0816 to $13.1581, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.338 to $13.61, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.1 to $13.15, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.46 to $13.4684, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Thomas B. Rosedale (Pursuant to Power of Attorney) 2020-07-16